About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Articles

Electro-energetics of Biventricular, Septal and Conduction System Pacing

Published:

15 December 2021

Citation:

Arrhythmia & Electrophysiology Review 2021;10(4):250–7.

Clinical Utility of Body Surface Potential Mapping in CRT Patients

Published:

13 July 2021

Citation:

Arrhythmia & Electrophysiology Review 2021;10(2):113–9.

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy

Published:

12 April 2021

Citation:

Arrhythmia & Electrophysiology Review 2021;10(1):26–32.

Ivabradine and AF: Coincidence, Correlation or a New Treatment?

Published:

11 February 2020

Citation:

Arrhythmia & Electrophysiology Review 2019;8(4):300–3.